Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Coya Therapeutics Inc COYA

Healthcare Biotechnology
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It develops COYA 302, a biologic combination for subcutaneous administration... see more

Current News (NDAQ:COYA)

Coya Therapeutics Announces Results of Investigator-Initiated Study of LD IL-2 and CTLA4-Ig Demonstrating Treg Enhancement and Cognitive Stability in Frontotemporal Dementia Patients

Business Wire 4 days ago

Coya Therapeutics Receives Clinical Trial Application (CTA) Acceptance from Health Canada to Proceed with the COYA 302 ALSTARS Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Business Wire December 23, 2025

Coya Therapeutics Announces Patients Have Been Dosed in the ALSTARS Trial of COYA 302 for the Treatment of ALS

Business Wire December 9, 2025

Coya Therapeutics to Participate in Upcoming Investor Relations and Clinical Trials Conferences

Business Wire November 25, 2025

Coya Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update

Business Wire November 12, 2025

Coya Therapeutics Announces That Its Combination LD IL-2/GLP-1 RA Candidate (COYA 303) Demonstrated Potent Systemic and Brain Anti-Inflammatory Efficacy In Vivo

Business Wire November 4, 2025

Coya Therapeutics Announces Closing of $23.0 Million Upsized Public Offering of Common Stock, Including Full Exercise of Underwriter's Option to Purchase Additional Shares

Business Wire October 27, 2025

Coya Therapeutics Announces Pricing of $20 Million Upsized Public Offering of Common Stock

Business Wire October 24, 2025

Coya Therapeutics Announces Proposed Public Offering of Common Stock

Business Wire October 23, 2025
View More News ››

Opinion & Analysis (NDAQ:COYA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:COYA)

New update from COYA!

https://youtu.be/IKdQqWEgPys
BryceCanada - June 3, 2025

Coya Therapeutics, Inc. (NASDAQ:COYA): A Promising Biotech P

http://beyondspx.com/2024/07/31/coya-therapeutics-inc-nasdaqcoya-a-promising-biotech-poised-for-significant-growth/
MikeTester - August 2, 2024

Huge news to start the year for COYA!

https://youtu.be/SEh4ra1xKtM?si=mMoM3EDtm0zzlUhb
BryceCanada - January 4, 2024

New video out from COYA CEO

https://youtu.be/Hg5B8IbmRxU?si=4ybR64kYvKuRUVDW
BryceCanada - October 26, 2023

Excellent YT analysis on COYA!

https://youtu.be/0AmM1T6lkN0
BryceCanada - March 6, 2023
View more Bullboard ››

TomaGold Corp.

TomaGold Corp.

TomaGold Corporation, together with its subsidiaries, engages in the acquisition, exploration, assessment, and development of ...
View More »

Podcasts